Biocryst Pharmaceuticals Inc

BCRX

Log in to follow and get free email alerts when insiders file.

Sector

Biological Products, Except Diagnostic Substances

Industry

Drugs

Recent Filings - SEC Insider Transactions (Form 3,4,5)

Date
  • today
  • yesterday
  • week
Price per share
Shares

Transaction Codes

File Date
 
Date
 
Company
 
Filer
 
Security
 
Shares
 
Price
 
$ Total
 
% Change
 
10%
 
Dir.
 
Off.
 
Code
 
View
 
SEC
 
SIC
 
SIC Group
 
SIC Division
 

      Rows per page:

      100

      0-0 of 0

    Buy / Sell (dollars)

    1 Month

    18.4%81.6%

    $363,450.00

    avg. $363,450.00

    $1.62M

    avg. $1.62M

    Buy/Sell Ratio

    0.225


    Transactions

    5

    Filers

    1

    3 Month

    18.9%81.1%

    $658,192.24

    avg. $658,192.24

    $2.83M

    avg. $941,920.00

    Buy/Sell Ratio

    0.233


    Transactions

    15

    Filers

    10

    12 Month

    27.3%72.7%

    $3.28M

    avg. $3.28M

    $8.73M

    avg. $727,840.18

    Buy/Sell Ratio

    0.376


    Transactions

    50

    Filers

    43

    24 Month

    29.3%70.7%

    $3.63M

    avg. $3.63M

    $8.73M

    avg. $363,920.09

    Buy/Sell Ratio

    0.415


    Transactions

    66

    Filers

    84

    Filers

    CIK
    Name
    Title
    Last Transaction
    First Transaction
    Director
    Officer
    10% Own.
    Other
    1379222Hutson Nancy J2021-10-192019-12-03
    1883764McKee Amy E2021-09-222021-09-22
    1208570LEE KENNETH B JR2021-09-152020-05-14
    1485939ABERCROMBIE GEORGE B2021-09-142020-05-14
    1174452LEVIN ALAN G2021-09-022020-03-03
    1495328Galson Steven K2021-09-022021-09-02
    1760020HEGGIE THERESA2021-09-022019-12-03
    1219890INGRAM ROBERT ALEXANDER2021-09-022019-12-03
    1221599ASELAGE STEVE2021-09-022019-11-18
    1187159MILANO VINCENT2021-07-282021-07-28
    1439174Sheridan William PSenior VP - CMO2021-06-012019-12-19
    1584348Barnes Alane PSenior VP, Chief Legal Officer2021-05-132019-11-18
    1800060Jones Michael LExec. Director, Finance - PAO2021-03-222020-12-07
    1452635Babu Yarlagadda SSenior VP - Drug Discovery2021-02-232019-11-18
    1808688Doyle AnthonyChief Financial Officer2020-12-172020-05-04